LivingGLP1
parallel randomized trial

S003067

Design

Randomized
564
Start year
2007
Treatment
52 weeks, follow-up 52 weeks
Countries
multinational (19 sites)
Sponsor
Novo Nordisk (industry)
Eligibility
age 18 to 65; BMI 30 to 40; FPG below 7 mmol/L; no diabetes

Conduct and analysis

Blinding
double blind
Sequence generation
other adequate
Allocation concealment
central
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
modified itt
Missing data
LOCF

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Placebo
Placebo
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9898
A2Liraglutide 1.2 mg subcutaneous once daily
Liraglutide 1.2 mg
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9594
A3Liraglutide 1.8 mg subcutaneous once daily
Liraglutide 1.8 mg
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9090
A4Liraglutide 2.4 mg injection once daily
Liraglutide 2.4 mg
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9392
A5Liraglutide 3.0 mg subcutaneous once daily
Liraglutide 3.0 mg
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9392
A6Orlistat
Orlistat 120 mg three times daily
diet with 500 kcal daily deficit and activity advice; lifestyle: standard9595

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticPlacebo
A1
Liraglutide 1.2 mg subcutaneous once daily
A2
Liraglutide 1.8 mg subcutaneous once daily
A3
Liraglutide 2.4 mg injection once daily
A4
Liraglutide 3.0 mg subcutaneous once daily
A5
Orlistat
A6
agemean (years)45.947.245.545.045.945.9
agesd (years)10.39.710.911.110.79.1
bmimean (kg/m2)34.934.835.035.034.834.1
bmisd (kg/m2)2.82.62.62.82.82.6
femalepercent757776767577
hba1cmean (percent)5.65.65.65.55.65.6
hba1csd (percent)0.40.30.40.30.40.3
sbpmean (mmHg)124127123126124123
sbpsd (mmHg)11.113.113.013.911.313.5
waistmean (cm)108109108110109108
waistsd (cm)10.010.49.510.78.39.7
weightmean (kg)97.396.298.098.497.696.0
weightsd (kg)12.313.512.513.013.711.7

Analyses this trial contributes to

Results

82 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (28 lines; O05)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
52A1change-1.6 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A1change-0.2 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A2change-4.2 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A2change-3.9 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A2 vs A1md-2.4 mmHg-6.4 to 1.6not stated; modified itt; R0025439:Supplement Table 3
52A2 vs A1md-3.7 mmHg-8.1 to 0.8not stated; modified itt; R0025439:Supplement Table 3
52A2 vs A6md-1.8 mmHg-5.7 to 2.0not stated; modified itt; R0025439:Supplement Table 3
52A2 vs A6md-2.1 mmHg-6.6 to 2.5not stated; modified itt; R0025439:Supplement Table 3
52A3change-4.0 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A3change-2.8 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A3 vs A1md-2.3 mmHg-6.3 to 1.7not stated; modified itt; R0025439:Supplement Table 3
52A3 vs A1md-2.6 mmHg-7.1 to 2.0not stated; modified itt; R0025439:Supplement Table 3
52A3 vs A6md-1.7 mmHg-5.6 to 2.2not stated; modified itt; R0025439:Supplement Table 3
52A3 vs A6md-1.0 mmHg-5.6 to 3.7not stated; modified itt; R0025439:Supplement Table 3
52A4change-7.0 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A4change-6.3 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A4 vs A1md-5.3 mmHg-9.2 to -1.3not stated; modified itt; R0025439:Supplement Table 3
52A4 vs A1md-6.0 mmHg-10.5 to -1.6not stated; modified itt; R0025439:Supplement Table 3
52A4 vs A6md-4.7 mmHg-8.6 to -0.9not stated; modified itt; R0025439:Supplement Table 3
52A4 vs A6md-4.4 mmHg-9.0 to 0.1not stated; modified itt; R0025439:Supplement Table 3
52A5change-4.9 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A5change-5.4 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A5 vs A1md-3.3 mmHg-7.3 to 0.7not stated; modified itt; R0025439:Supplement Table 3
52A5 vs A1md-5.2 mmHg-9.5 to -0.8not stated; modified itt; R0025439:Supplement Table 3
52A5 vs A6md-2.5 mmHg-6.4 to 1.4not stated; modified itt; R0025439:Supplement Table 3
52A5 vs A6md-3.6 mmHg-8.1 to 0.9not stated; modified itt; R0025439:Supplement Table 3
52A6change-2.3 mmHgnot stated; modified itt; R0025439:Supplement Table 3
52A6change-1.8 mmHgnot stated; modified itt; R0025439:Supplement Table 3
Weight loss of 5 percent or more (6 lines; O11A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
52A1responders2898not stated; modified itt; R0025439:Figure 2
52A2responders4394not stated; modified itt; R0025439:Figure 2
52A3responders5190not stated; modified itt; R0025439:Figure 2
52A4responders5392not stated; modified itt; R0025439:Figure 2
52A5responders7392not stated; modified itt; R0025439:Figure 2
52A6responders4495not stated; modified itt; R0025439:Figure 2
Weight loss of 10 percent or more (6 lines; O11B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
52A1responders1098not stated; modified itt; R0025439:Figure 2
52A2responders1794not stated; modified itt; R0025439:Figure 2
52A3responders2690not stated; modified itt; R0025439:Figure 2
52A4responders2792not stated; modified itt; R0025439:Figure 2
52A5responders3792not stated; modified itt; R0025439:Figure 2
52A6responders1495not stated; modified itt; R0025439:Figure 2
Physical functioning (any instrument) (6 lines; O24B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
52A1change8.7 points15not stated; modified itt; R0025439:Supplement Table 7
52A2change7.7 points13not stated; modified itt; R0025439:Supplement Table 7
52A3change11 points16not stated; modified itt; R0025439:Supplement Table 7
52A4change9.1 points16not stated; modified itt; R0025439:Supplement Table 7
52A5change14 points16not stated; modified itt; R0025439:Supplement Table 7
52A6change11 points12not stated; modified itt; R0025439:Supplement Table 7
Serious adverse events (6 lines; O25)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events3 / 98not stated; randomized; R0025439:Table 2
A2events2 / 95not stated; randomized; R0025439:Table 2
A3events7 / 90not stated; randomized; R0025439:Table 2
A4events4 / 93not stated; randomized; R0025439:Table 2
A5events7 / 93not stated; randomized; R0025439:Table 2
A6events2 / 95not stated; randomized; R0025439:Table 2
Discontinuation due to adverse events (6 lines; O26)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events3 / 98not stated; randomized; R0025439:Table 2
A2events5 / 95not stated; randomized; R0025439:Table 2
A3events6 / 90not stated; randomized; R0025439:Table 2
A4events12 / 93not stated; randomized; R0025439:Table 2
A5events7 / 93not stated; randomized; R0025439:Table 2
A6events3 / 95not stated; randomized; R0025439:Table 2
Nausea (6 lines; O27A)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events7 / 98not stated; randomized; R0025439:Table 2
A2events23 / 95not stated; randomized; R0025439:Table 2
A3events29 / 90not stated; randomized; R0025439:Table 2
A4events35 / 93not stated; randomized; R0025439:Table 2
A5events45 / 93not stated; randomized; R0025439:Table 2
A6events7 / 95not stated; randomized; R0025439:Table 2
Vomiting (6 lines; O27B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events2 / 98not stated; randomized; R0025439:Table 2
A2events5 / 95not stated; randomized; R0025439:Table 2
A3events9 / 90not stated; randomized; R0025439:Table 2
A4events14 / 93not stated; randomized; R0025439:Table 2
A5events12 / 93not stated; randomized; R0025439:Table 2
A6events2 / 95not stated; randomized; R0025439:Table 2
Diarrhea (6 lines; O27C)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events10 / 98not stated; randomized; R0025439:Table 2
A2events8 / 95not stated; randomized; R0025439:Table 2
A3events9 / 90not stated; randomized; R0025439:Table 2
A4events12 / 93not stated; randomized; R0025439:Table 2
A5events14 / 93not stated; randomized; R0025439:Table 2
A6events28 / 95not stated; randomized; R0025439:Table 2
Constipation (6 lines; O27D)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events12 / 98not stated; randomized; R0025439:Table 2
A2events15 / 95not stated; randomized; R0025439:Table 2
A3events11 / 90not stated; randomized; R0025439:Table 2
A4events21 / 93not stated; randomized; R0025439:Table 2
A5events17 / 93not stated; randomized; R0025439:Table 2
A6events7 / 95not stated; randomized; R0025439:Table 2